Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An open trial of fluvoxamine for hypochondriasis.
Fallon BA, Qureshi AI, Schneier FR, Sanchez-Lacay A, Vermes D, Feinstein R, Connelly J, Liebowitz MR. Fallon BA, et al. Among authors: vermes d. Psychosomatics. 2003 Jul-Aug;44(4):298-303. doi: 10.1176/appi.psy.44.4.298. Psychosomatics. 2003. PMID: 12832595 Clinical Trial.
A double-masked, placebo-controlled study of fluoxetine for hypochondriasis.
Fallon BA, Petkova E, Skritskaya N, Sanchez-Lacay A, Schneier F, Vermes D, Cheng J, Liebowitz MR. Fallon BA, et al. Among authors: vermes d. J Clin Psychopharmacol. 2008 Dec;28(6):638-45. doi: 10.1097/JCP.0b013e31818d21cf. J Clin Psychopharmacol. 2008. PMID: 19011432 Clinical Trial.
A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.
Blanco C, Heimberg RG, Schneier FR, Fresco DM, Chen H, Turk CL, Vermes D, Erwin BA, Schmidt AB, Juster HR, Campeas R, Liebowitz MR. Blanco C, et al. Among authors: vermes d. Arch Gen Psychiatry. 2010 Mar;67(3):286-95. doi: 10.1001/archgenpsychiatry.2010.11. Arch Gen Psychiatry. 2010. PMID: 20194829 Free PMC article. Clinical Trial.
COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.
Schneier FR, Campeas R, Carcamo J, Glass A, Lewis-Fernandez R, Neria Y, Sanchez-Lacay A, Vermes D, Wall MM. Schneier FR, et al. Among authors: vermes d. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. Epub 2015 Jun 26. Depress Anxiety. 2015. PMID: 26115513 Free PMC article. Clinical Trial.
The pharmacotherapy of hypochondriasis.
Fallon BA, Schneier FR, Marshall R, Campeas R, Vermes D, Goetz D, Liebowitz MR. Fallon BA, et al. Among authors: vermes d. Psychopharmacol Bull. 1996;32(4):607-11. Psychopharmacol Bull. 1996. PMID: 8993081 Review.
Childhood trauma and dissociative symptoms in panic disorder.
Marshall RD, Schneier FR, Lin SH, Simpson HB, Vermes D, Liebowitz M. Marshall RD, et al. Among authors: vermes d. Am J Psychiatry. 2000 Mar;157(3):451-3. doi: 10.1176/appi.ajp.157.3.451. Am J Psychiatry. 2000. PMID: 10698824
Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB, Foa EB, Liebowitz MR, Huppert JD, Cahill S, Maher MJ, McLean CP, Bender J Jr, Marcus SM, Williams MT, Weaver J, Vermes D, Van Meter PE, Rodriguez CI, Powers M, Pinto A, Imms P, Hahn CG, Campeas R. Simpson HB, et al. Among authors: vermes d. JAMA Psychiatry. 2013 Nov;70(11):1190-9. doi: 10.1001/jamapsychiatry.2013.1932. JAMA Psychiatry. 2013. PMID: 24026523 Free PMC article. Clinical Trial.
Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder.
Foa EB, Simpson HB, Liebowitz MR, Powers MB, Rosenfield D, Cahill SP, Campeas R, Franklin M, Hahn CG, Hembree EA, Huppert JD, Schmidt AB, Vermes D, Williams MT. Foa EB, et al. Among authors: vermes d. J Clin Psychiatry. 2013 May;74(5):464-9. doi: 10.4088/JCP.12m08017. J Clin Psychiatry. 2013. PMID: 23759449 Free PMC article. Clinical Trial.
23 results